1. P1509: BONE MARROW TFR2 GENETIC DELETION ABROGATES BLOOD TRANFUSION REQUIREMENT IN THE HBBTH1/TH2 Β-THALASSEMIC MURINE MODEL. (23rd June 2022) Authors: Di Modica, S. M.; Tanzi, E.; Olivari, V.; Lidonnici, M. R.; Pettinato, M.; Pagani, A.; Tiboni, F.; Ferrari, G.; Silvestri, L.; Rivella, S.; Nai, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1390 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S271: BONE MARROW TFR2 DELETION IMPROVES THE THERAPEUTIC EFFECT OF ACTIVIN LIGAND TRAP RAP-536 IN Β-THALASSEMIC MICE. (23rd June 2022) Authors: Tanzi, E.; Di Modica, S. M; Bordini, J.; Olivari, V.; Pettinato, M.; Pagani, A.; Campanella, A.; Silvestri, L.; Nai, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S276: TRANSFERRIN RECEPTOR 2 TARGETING AMELIORATES DIFFERENT FORMS OF ANEMIA CAUSED BY CHRONIC INFLAMMATION. (23rd June 2022) Authors: Olivari, V.; Lidonnici, M. R.; Tanzi, E.; Di Modica, S. M.; Tiboni, F.; Silvestri, L.; Ferrari, G.; Nai, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗